ConductScience.org, home

Paper36722665

Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.

Ráduly AP and 9 others. ESC Heart Fail, 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels. Papers, record 36722665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36722665

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
PubMed
Journal
ESC Heart Fail
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2026-01-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ráduly APArnold Péter
2Tóth AAttila
3Sárkány FFruzsina
4Horváth BBalázs
5Szentandrássy NNorbert
6Nánási PPPéter P
7Csanádi ZZoltán
8Édes IIstván
9Papp ZZoltánhttps://orcid.org/0000-0002-4675-1542
10Borbély AAttila

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myocytes, CardiacMajor topic
Heart FailureMajor topic
Animals
Dogs
Stroke Volume
Simendan
Myosins
Urea

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128668303Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization.J Mol Cell Cardiol2017https://conductscience.org/library/papers/28668303PubMed
227012405Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.J Am Coll Cardiol2016https://conductscience.org/library/papers/27012405PubMed
316116344Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.J Cardiovasc Pharmacol2005https://conductscience.org/library/papers/16116344PubMed
426140433The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.Br J Pharmacol2015https://conductscience.org/library/papers/26140433PubMed
532035892Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF.JACC Heart Fail2020https://conductscience.org/library/papers/32035892PubMed
621856481The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.Lancet2011https://conductscience.org/library/papers/21856481PubMed
725680381Omecamtiv Mecarbil modulates the kinetic and motile properties of porcine β-cardiac myosin.Biochemistry2015https://conductscience.org/library/papers/25680381PubMed
827914656Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.Lancet2016https://conductscience.org/library/papers/27914656PubMed
914751410The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig.Eur J Pharmacol2004https://conductscience.org/library/papers/14751410PubMed
1015750836Sarcomeric determinants of striated muscle relaxation kinetics.Pflugers Arch2005https://conductscience.org/library/papers/15750836PubMed
1124520162Small molecule-mediated refolding and activation of myosin motor function.Elife2014https://conductscience.org/library/papers/24520162PubMed
121880816A novel positive inotropic substance enhances contractility without increasing the Ca2+ transient in rat myocardium.J Mol Cell Cardiol1991https://conductscience.org/library/papers/1880816PubMed
1325068717Analytical comparison of natural and pharmaceutical ventricular myosin activators.Biochemistry2014https://conductscience.org/library/papers/25068717PubMed
1421856480Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.Lancet2011https://conductscience.org/library/papers/21856480PubMed
1528792844TRPA1 ion channel stimulation enhances cardiomyocyte contractile function via a CaMKII-dependent pathway.Channels (Austin)2017https://conductscience.org/library/papers/28792844PubMed
1621784540Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.Int J Cardiol2012https://conductscience.org/library/papers/21784540PubMed
1728940010Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.Naunyn Schmiedebergs Arch Pharmacol2017https://conductscience.org/library/papers/28940010PubMed
1820498236Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.Circ Heart Fail2010https://conductscience.org/library/papers/20498236PubMed
1925260618Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.Am J Physiol Heart Circ Physiol2014https://conductscience.org/library/papers/25260618PubMed
208384421Enantiomeric dissection of the effects of the inotropic agent, EMD 53998, in single cardiac myocytes.Am J Physiol1993https://conductscience.org/library/papers/8384421PubMed

See all 30 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42806179Substrate-Dependent Pro- and Antiarrhythmic Action of Omecamtiv Mecarbil at the Ventricular and Atrial Level: Insights from a Langendorff-Perfused Rabbit Heart Model.Cardiovasc Toxicol2026https://conductscience.org/library/papers/42806179PubMed
41384329Diffusion Tensor CMR Assessment of the Microstructural Response to Dobutamine Stress in Health and Comparison With Patients With Recovered Dilated Cardiomyopathy.Circ Cardiovasc Imaging2026https://conductscience.org/library/papers/41384329PubMed
40831223Insights from electromechanical simulations to assess omecamtiv mecarbil efficacy in heart failure.J Physiol2026https://conductscience.org/library/papers/40831223PubMed
39927371Pharmacodynamics of single-dose omecamtiv mecarbil administered intravenously in clinically healthy cats.Open Vet J2024https://conductscience.org/library/papers/39927371PubMed
39802175Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure.J Mol Cell Cardiol Plus2023https://conductscience.org/library/papers/39802175PubMed
38566963Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future.Front Cardiovasc Med2024https://conductscience.org/library/papers/38566963PubMed
38338853Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights.Int J Mol Sci2024https://conductscience.org/library/papers/38338853PubMed
37239022Characterization of Stimulatory Action on Voltage-Gated Na+ Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator.Biomedicines2023https://conductscience.org/library/papers/37239022PubMed
36722665Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.ESC Heart Fail2023https://conductscience.org/library/papers/36722665PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MYH1479784PubTator's text mininghttps://conductscience.org/library/genes/79784

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36722665

GET https://conductscience.org/api/papers/v1/36722665/references?page=2